The Rationale For Genetically Profiling AML Patients

Robert Rifkin, MD, Hematologist/Oncologist, Associate Chair, US Oncology Hematology Research, Rocky Mountain Cancer Centers, discusses The Rationale For Genetically Profiling AML Patients. At The 60th... Author: obr Added: 01/15/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts